drugset / Trial / NCT00839306
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the efficacy of rabeprazole extended release 50 mg (once daily) versus ranitidine 150 mg (twice daily) in the maintenance of complete healing in subjects with healed erosive gastroesophageal reflux disease (eGERD).
Timeline
- Start
- 2008-08
- Primary completion
- 2009-08
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rabeprazole | Small molecule | 50 mg | Oral |
| Comparator | Ranitidine | Unknown | 150 mg | Oral |